About Cardurion Pharmaceuticals

Website
Website
Employees
Employees
11-50 employees View all
Industry
Industry
Biotechnology
Location
Location
31 St James Ave, Sixth Floor, Boston, Massachusetts 02116, US
Description
Information
Cardurion is a clinical-stage cardiovascular biotechnology company developing new therapeutics for the treatment of heart failure and cardiovascular diseases. Cardurion’s product pipeline includes our lead clinical asset, CRD-733, a PDE-9 inhibitor with the potential to improve cardiac function in heart failure patients. Cardurion has an exclusive licensing agreement with Astellas for the development and commercialization of CRD-733. Additionally, Cardurion has a strong cardiovascular development partnership with Takeda which is fueling drug discovery and preclinical development work being conducted in our internal research laboratories.

Cardurion Pharmaceuticals Alternatives

Industry
Biotechnology
Industry
Biotechnology
Industry
Biotechnology
Industry
Biotechnology
Industry
Biotechnology
Industry
biotechnology
Industry
biotechnology

Frequently Asked Questions about Cardurion Pharmaceuticals

What is Cardurion Pharmaceuticals email format?

The widely used Cardurion Pharmaceuticals email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.


What is Cardurion Pharmaceuticals customer service number?

To contact Cardurion Pharmaceuticals customer service number in your country click here to find.


Who is the CEO of Cardurion Pharmaceuticals?

Jennifer Lassiter is the CEO of Cardurion Pharmaceuticals. To contact Jennifer Lassiter email at [email protected].


Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more